AstraZeneca contributes meaningfully to the UK beyond the provision of our medicines and the benefits they provide to the health of the nation.
We commissioned a report in 2009 to measure our significant investment to the UK economy, which includes investment in jobs and wealth creation. Oxera, an independent economic consultancy provided the analysis for this report.
The report looks at our contribution to the UK as a whole as well as at individual countries within the UK, and at regions where AstraZeneca has a significant presence, identifying the company’s local impact in terms of spending, jobs and economic prosperity.
-
The report
AstraZeneca’s Economic and Business Contribution to the UK - 2009 update
Click here to read the full report.
The analysis of the economic impact in this report was commissioned from Oxera by AstraZeneca. Oxera is one of the UK’s leading independent economic consultancies.